Related Experiment Video
Updated: Jun 15, 2025
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
Published on: March 18, 2015
Strategies for arterial graft optimization at the single-cell level
Zhan Hu1,2, Min Dai3,4, Yuan Chang1,2
1Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Animal Experimental Centre, Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
This study analyzed arterial grafts for coronary artery bypass grafting, identifying cellular differences to optimize radial artery (RA) and right gastroepiploic artery (RGA) grafts using the internal thoracic artery (ITA) as a benchmark.
Area of Science:
- Vascular biology and regenerative medicine.
- Single-cell transcriptomics.
- Biomaterial science for cardiovascular applications.
Background:
- Internal thoracic artery (ITA) grafts show superior outcomes in coronary artery bypass grafting (CABG).
- Radial artery (RA) and right gastroepiploic artery (RGA) are alternative grafts with varying clinical performance.
- Understanding cellular differences can guide graft optimization.
Purpose of the Study:
- To identify cellular and molecular differences between ITA, RA, and RGA grafts.
- To propose optimization strategies for RA and RGA grafts based on ITA characteristics.
- To explore potential therapeutic targets for improving arterial graft function.
Main Methods:
- Single-cell RNA sequencing of endothelial cells, vascular smooth muscle cells, and fibroblasts from different arterial grafts.
- Bioinformatic analysis of cell-cell communication pathways.
- In vivo validation of identified targets in a mouse model of neointimal hyperplasia.
Main Results:
- RA grafts exhibit increased CD36+ endothelial cells involved in lipid handling compared to ITA.
- RGA and RA vascular smooth muscle cells are more prone to spasm; ITA comparison suggests potassium channel openers as a countermeasure.
- Fibroblasts in RA and RGA express GDF10 and CREB5, respectively, linked to extracellular matrix deposition.
- Macrophage migration inhibitory factor (MIF) signaling is elevated in RA, and MIF inhibition reduces neointimal hyperplasia in vivo.
Conclusions:
- Cellular heterogeneity among arterial grafts provides a basis for targeted optimization strategies.
- Modulating identified pathways, such as MIF signaling and extracellular matrix deposition, may enhance arterial graft patency and reduce complications.
- This research offers insights into improving the long-term success of CABG procedures through graft selection and modification.
